Tubular biomarkers to assess progression of diabetic nephropathy

Kidney International

Volumn 79, Issue 10, 2011, Pages 1042-1044

  Tramonti, Gianfranco ^a   Kanwar, Yashpal S ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; KIDNEY INJURY MOLECULE 1; LIVER FATTY ACID BINDING PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE MARKER; GLOMERULUS FILTRATION RATE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEIN URINE LEVEL; PROTEINURIA; REVIEW; URINARY EXCRETION;

EID: 79955595112     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2011.9     Document Type: Note

References (13)

1. Gilbert RE, Cooper ME. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56: 1627-1637. (Pubitemid 29518163)
2. Abbate M, Benigni A, Bertani T, Remuzzi G. Nephrotoxicity of increased glomerular protein traffic. Nephrol Dial Transplant 1999; 14: 304-312. (Pubitemid 29062783)
3. Nielsen SE, Andersen S, Zdunek D et al. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int 2011; 79: 1113-1118.
4. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL). A new marker of kidney disease. Scand J Clin Lab Invest Suppl 2008; 241: 89-94. (Pubitemid 351883665)
5. Devarajan P. The use of targeted biomarkers for chronic kidney disease. Adv Chronic Kidney Dis 2010; 17: 469-479.
6. Kuehn EW, Hirt MN, John A-K et al. Kidney injury molecule 1 (Kim1) is a novel ciliary molecule and interactor of polycystin 2. Biochem Biophys Res Commun 2007; 364: 861-866. (Pubitemid 350087881)
7. Kelly DJ, Cox AJ, Tolcos M et al. Attenuation of tubular apoptosis by blockade of the reninangiotensin system in diabetic Ren-2 rats. Kidney Int 2002; 61: 31-39. (Pubitemid 34075128)
8. Kamijo A, Sugaya T, Hikawa A et al. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 2006; 284: 175-182. (Pubitemid 44404425)
9. Nath KA. The tubulointerstitium in progressive renal disease. Kidney Int 1998; 54: 992-994. (Pubitemid 28397421)
10. Branten AJ, Vervoort G, Wetzels JF. Serum creatinine is a poor marker of GFR in nephrotic syndrome. Nephrol Dial Transplant 2005; 20: 707-711. (Pubitemid 40520646)
11. Vervoort G, Willems HL, Wetzels JF. Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant 2002; 17: 1909-1913. (Pubitemid 35277086)
12. Ibrahim H, Mondress M, Tello A et al. An alternative formula to the Cockcroft-Gault and the modification of diet in renal diseases formulas in predicting GFR in individuals with type 1 diabetes. J Am Soc Nephrol 2005; 16: 1051-1060. (Pubitemid 41710315)
13. Standards of medical care in diabetes-2009. American Diabetes Association. Diabetes Care 2009; 32 (Suppl 1): S13-S61 .